(2S,3S)-2-amino-3-methylpentanoicacid-13C; (2S,3S)-2-Amino-3-methylpentanoic aAid-13C; (2S,3S)-?-Amino-?-methyl-n-valeric Acid-13C; (2S,3S)-?-Amino-?-methylvaleric Acid-13C; (S)-Isoleucine-13C; (S,S)-Isoleucine-13C; 1579: PN: EP2071334 SEQID: 1669 Claimed Protein-13C; 1579: PN: WO2009077864 SEQID: 1669 Claimed Protein-13C; 2-Amino-3-methylvaleric Acid-13C; 2S,3S-Isoleucine-13C; 9: PN: US20090069547 PAGE: 10 Claimed Protein-13C; Isoleucine-13C; L-(+)-Isoleucine-13C; L-Ile-13C; 3-Methyl-erythro-L-norvaline-13C; NSC 46708-13C; (2S,3S)-2-Amino-3-methylpentanoic Acid-13C; [S-(R*,R*)]-2-Amino-3-methylpentanoic Acid-13C; erythro-L-Isoleucine
Isoleucine-13C is a fully characterized chemical compound used as a reference standard of API Leucine. The standard offered is compliant with regulatory guidelines. Isoleucine-13C is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 73-32-5 (non-labelled)